You are here:Home-Chemical Inhibitors & Agonists-PI3K/Akt/mTOR Pathway-mTOR-Everolimus
Everolimus

Chemical Structure : Everolimus

CAS No.: 159351-69-6

Everolimus (RAD001;SDZ-RAD;RAD-001)

Catalog No.: PC-42463Not For Human Use, Lab Use Only.

Everolimus (RAD001) is a potent, highly specific, orally active mTOR inhibitor with IC50 of 5-6 nM for binding to FKBP-12 or FKBP-12 complexed to mTOR.

Packing Price Stock Quantity
25 mg $128 In stock
100 mg $298 In stock
200 mg Get quote
1 g Get quote
5 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Everolimus (RAD001) is a potent, highly specific, orally active mTOR inhibitor with IC50 of 5-6 nM for binding to FKBP-12 or FKBP-12 complexed to mTOR.
Everolimus (RAD001)  inhibits proliferation in vitro (IC50=1 nM-1 uM) in sensitive and insensitive tumor.
Everolimus (RAD001)  dose-dependently inhibits tumor growth in vivo.

Physicochemical Properties

M.Wt 958.2244
Formula C53H83NO14
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 54 mg/mL

Chemical Name/SMILES

Rapamycin, 42-O-(2-hydroxyethyl)-

References

1. Sedrani R, et al. Transplant Proc. 1998 Aug;30(5):2192-4.

2. Schuler W, et al. Transplantation. 1997 Jul 15;64(1):36-42.

3. Lane HA, et al. Clin Cancer Res. 2009 Mar 1;15(5):1612-22.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: